Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rahal

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Carcinogenesis|January 6, 2012
Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cellsMaria Theresa E Montales, Omar M Rahal, Jie Kang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal typeN Azli, J P Armand, M Rahal, et al.
Journal of the National Cancer Institute|April 4, 1990
High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapyM Bachouchi, E Cvitkovic, N Azli, et al.
The Cancer Journal From Scientific American|October 1, 1995
Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal typeN Azli, A Fandi, M Bachouchi, et al.
Medical Oncology (Northwood, London, England)|May 25, 2002
HER-2/Neu overexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancerAsma M Tulbah, Ezzeldin M Ibrahim, Adnan A Ezzat, et al.
Cancer|October 15, 1990
Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycinH Sadek, N Azli, J L Wendling, et al.
Stem Cell Research|September 10, 2013
Dietary suppression of the mammary CD29(hi)CD24(+) epithelial subpopulation and its cytokine/chemokine transcriptional signatures modifies mammary tumor risk in MMTV-Wnt1 transgenic miceOmar M Rahal, Heather L Machado, Maria Theresa E Montales, et al.
Medical Oncology (Northwood, London, England)|March 14, 2000
Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trialA A Ezzat, E M Ibrahim, R K Stuart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Primary gastric non-Hodgkin's lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphomaE M Ibrahim, A A Ezzat, M A Raja, et al.
Carcinogenesis|November 13, 2012
Suppression of Wnt1-induced mammary tumor growth and lower serum insulin in offspring exposed to maternal blueberry diet suggest early dietary influence on developmental programmingOmar M Rahal, John Mark P Pabona, Thomas Kelly, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Carcinogenesis|January 6, 2012
Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cellsMaria Theresa E Montales, Omar M Rahal, Jie Kang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal typeN Azli, J P Armand, M Rahal, et al.
Journal of the National Cancer Institute|April 4, 1990
High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapyM Bachouchi, E Cvitkovic, N Azli, et al.
The Cancer Journal From Scientific American|October 1, 1995
Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal typeN Azli, A Fandi, M Bachouchi, et al.
Medical Oncology (Northwood, London, England)|May 25, 2002
HER-2/Neu overexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancerAsma M Tulbah, Ezzeldin M Ibrahim, Adnan A Ezzat, et al.
Cancer|October 15, 1990
Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycinH Sadek, N Azli, J L Wendling, et al.
Stem Cell Research|September 10, 2013
Dietary suppression of the mammary CD29(hi)CD24(+) epithelial subpopulation and its cytokine/chemokine transcriptional signatures modifies mammary tumor risk in MMTV-Wnt1 transgenic miceOmar M Rahal, Heather L Machado, Maria Theresa E Montales, et al.
Medical Oncology (Northwood, London, England)|March 14, 2000
Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trialA A Ezzat, E M Ibrahim, R K Stuart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Primary gastric non-Hodgkin's lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphomaE M Ibrahim, A A Ezzat, M A Raja, et al.
Carcinogenesis|November 13, 2012
Suppression of Wnt1-induced mammary tumor growth and lower serum insulin in offspring exposed to maternal blueberry diet suggest early dietary influence on developmental programmingOmar M Rahal, John Mark P Pabona, Thomas Kelly, et al.
Pageof 5